Documentation

Investor presentations

Datesort descending Title Document Webcast/Audio
30/11/2017 - 17:30 CET Key opinion leader breakfast on odiparcil, a novel treatment for MPS VI patients
07/03/2018 - 18:15 CET 2017 Full Year Results
12/03/2018 - 17:00 CET Inventiva’s presentation - 38th Annual Cowen Healthcare Conference
13/03/2018 - 17:45 CET Inventiva’s presentation - 30th Annual ROTH Conference: Company presentation
19/03/2018 - 17:45 CET Inventiva’s presentation - 2nd Annual H.C. Wainwright NASH Investor Conference
05/04/2018 - 19:00 CET Lanifibranor US Phase II study on Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes
09/04/2018 - 18:35 CET Corporate Presentation April 2018